Biosensors Show the Pharmacokinetics of S-Ketamine in the Endoplasmic Reticulum-Reference-Cited by-同舟云学术

Biosensors Show the Pharmacokinetics of S-Ketamine in the Endoplasmic Reticulum

Published:2019-11-12 Issue: Volume:13 Page:
ISSN:1662-5102
Container-title:Frontiers in Cellular Neuroscience
language:
Short-container-title:Front. Cell. Neurosci.

Author:

Bera Kallol,Kamajaya Aron,Shivange Amol V.,Muthusamy Anand K.,Nichols Aaron L.,Borden Philip M.,Grant Stephen,Jeon Janice,Lin Elaine,Bishara Ishak,Chin Theodore M.,Cohen Bruce N.,Kim Charlene H.,Unger Elizabeth K.,Tian Lin,Marvin Jonathan S.,Looger Loren L.,Lester Henry A.

Funder

National Institutes of Health

California Institute for Regenerative Medicine

National Alliance for Research on Schizophrenia and Depression

Publisher

Frontiers Media SA

Subject

Cellular and Molecular Neuroscience

Reference54 articles.

1. Calcium/calmodulin-dependent protein kinase II and eukaryotic elongation factor 2 kinase pathways mediate the antidepressant action of ketamine;Adaikkan;Biol. Psychiatry,2018

2. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses;Autry;Nature,2011

3. Deciphering the molecular mechanism responsible for GCaMP6m’s Ca2+-dependent change in fluorescence;Barnett;PLoS One,2017